Your browser doesn't support javascript.
loading
Assessing the clinical impact of CYP2C9 pharmacogenetic variation on phenytoin prescribing practice and patient response in an integrated health system.
Fohner, Alison E; Ranatunga, Dilrini K; Thai, Khanh K; Lawson, Brian L; Risch, Neil; Oni-Orisan, Akinyemi; Jelalian, Aline T; Rettie, Allan E; Liu, Vincent X; Schaefer, Catherine A.
Afiliación
  • Fohner AE; Division of Research, Kaiser Permanente Northern California, Oakland, California.
  • Ranatunga DK; Department of Epidemiology.
  • Thai KK; Institute of Public Health Genetics, University of Washington, Seattle, Washington.
  • Lawson BL; Division of Research, Kaiser Permanente Northern California, Oakland, California.
  • Risch N; Division of Research, Kaiser Permanente Northern California, Oakland, California.
  • Oni-Orisan A; Division of Research, Kaiser Permanente Northern California, Oakland, California.
  • Jelalian AT; Institute of Human Genetics.
  • Rettie AE; Institute of Human Genetics.
  • Liu VX; Department of Clinical Pharmacy, University of California San Francisco, San Francisco.
  • Schaefer CA; Department of Neurology, Kaiser Permanente Northern California, Walnut Creek, California.
Pharmacogenet Genomics ; 29(8): 192-199, 2019 10.
Article en En | MEDLINE | ID: mdl-31461080

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fenitoína / Citocromo P-450 CYP2C9 / Variantes Farmacogenómicas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmacogenet Genomics Año: 2019 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Fenitoína / Citocromo P-450 CYP2C9 / Variantes Farmacogenómicas Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Pharmacogenet Genomics Año: 2019 Tipo del documento: Article